Publications by authors named "Pavan Najran"

Claim this Profile
A
Ambulatory Same-Day Map-and-Treat Angiography for Selective Internal Radiation Therapy Using a Transradial Approach.
Joshua P Frost, Jon Bell, Jeremy Lawrance, Pavan Najran, Damian Mullan

Cureus· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability.
Clarisse Dromain, Anders Sundin, Pavan Najran, Hector Vidal Trueba, Marco Dioguardi Burgio

Neuroendocrinology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anomalous Branch of the Left Hepatic Artery With Pericardial, Diaphragmatic, Splenic and Gastric Supply During Selective Internal Radiotherapy (SIRT).
Naushad H Karim, Jon Bell, Damian Mullan, Jeremy Lawrance, Pavan Najran

Cureus· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radial Artery Access for Hepatic Chemosaturation: The First Description of Technical Feasibility.
Joshua P Frost, Pavan Najran, Jon Bell, Damian Mullan

Cureus· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Venting Gastrostomy in Malignant Bowel Obstruction: A Systematic Review.
Sreeharshan Thampy, Pavan Najran, Damian Mullan, Hans-Ulrich Laasch

J Palliat Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the Feasibility of SentiMag/Sienna+ for Detecting Inguinal Sentinel Nodes in Penile Cancer (SentiPen): An eUROGEN and National Cancer Research Institute Trial.
Paul Cleaveland, Maurice Lau, Arie Parnham, Brian Murby, David Ashworth, Pavan Najran

Eur Urol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Angela Lamarca, Joakim Crona, Maxime Ronot, Marta Opalinska, Carlos Lopez Lopez, Pavan Najran

Oncologist· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.
Angela Lamarca, Maxime Ronot, Salma Moalla, Joakim Crona, Marta Opalinska, Pavan Najran

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.
Pavan Najran, Angela Lamarca, Damian Mullan, Mairéad G McNamara, Thomas Westwood

Curr Oncol Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-operative treatment following hip fracture.
Pavan S Najran, Gulraj S Matharu, Keith M Porter

Injury· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis